CellSight Diagnosis

CellSight Diagnosis is a forward-thinking company founded by a dynamic team, including professionals from the fields of dentistry and oncology. The goal is to revolutionize leukemia diagnosis through advanced technology and comprehensive medical knowledge. They propose an innovative product that leverages artificial intelligence and image processing to enable early, accurate, and rapid diagnosis of acute leukemia. This software platform utilizes deep neural custom models to distinguish immature leukemic blasts from normal cells, facilitating precise diagnosis through microscopic image analysis. With a commitment to bridging the diagnostic gap and improving patient outcomes, CellSight Diagnosis is at the forefront of medical innovation, uniting expertise from diverse domains for a common purpose.